First of all it's "Repurposed" not "Repositioned".
Secondly Bucillamine was already repurposed for infectious disease. They were already planning to do flu trials. So it's not like they grabbed something off the shelf and said let's see if it sticks.
Revive isn't going to just blow millions of dollars for a phase 3 trial unless they have some idea that it works. Also with Dr. Boulware on the team, it's even more evident of it.
My friend i hope I'm wrong but you seem so different now, I remember 5 years ago when we were both in tobacco, i hope all is well with you. I feel that this is a great investment and it has an incredible subsidiary, again all should do their own DD